BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Grillo TG, Almeida LR, Beraldo RF, Marcondes MB, Queiróz DAR, da Silva DL, Quera R, Baima JP, Saad-Hossne R, Sassaki LY. Heart failure as an adverse effect of infliximab for Crohn's disease: A case report and review of the literature. World J Clin Cases 2021; 9(33): 10382-10391 [PMID: 34904114 DOI: 10.12998/wjcc.v9.i33.10382]
URL: https://www.wjgnet.com/2307-8960/full/v9/i33/10382.htm
Number Citing Articles
1
Thais Gagno Grillo, Caroline Ferreira da Silva Mazeto Pupo Silveira, Ana Elisa Valencise Quaglio, Renata de Medeiros Dutra, Julio Pinheiro Baima, Silmeia Garcia Zanati Bazan, Ligia Yukie Sassaki. Acute heart failure as an adverse event of tumor necrosis factor inhibitor therapy in inflammatory bowel disease: A review of the literatureWorld Journal of Cardiology 2023; 15(5): 217-228 doi: 10.4330/wjc.v15.i5.217
2
Sanjib Mondal, Prabal Barman, Pandiarajan Vignesh. Cardiovascular Abnormalities in Juvenile Dermatomyositis: A Scoping Review for the Clinical RheumatologistsFrontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.827539
3
Yuxiong Jiang, Youdong Chen, Qian Yu, Yuling Shi. Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis ComorbiditiesBioDrugs 2023; 37(1): 35 doi: 10.1007/s40259-022-00569-z
4
Malcolm Irani, Bincy Abraham. Choosing Therapy for Moderate to Severe Crohn’s DiseaseJournal of the Canadian Association of Gastroenterology 2023;  doi: 10.1093/jcag/gwad023
5
Shivkar Amara, Anusha Pasumarthi, Neil Parikh, Nilesh Kodali, Mark Lebwohl, George Monks. Psoriasis management tree based on comorbidityInternational Journal of Dermatology 2024;  doi: 10.1111/ijd.17497
6
Mohammad Reza Hatamnejad, Mersedeh Karvandi, Fateme Jodatfar, Nastaran Ebrahimi, Fatemeh Shojaeian, Shaghayegh Baradaran Ghavami, Hedieh Balaii, Mahdi Moeeni, Mohsen Rajabnia, Shabnam Shahrokh, Hamid Asadzadeh Aghdaei. Evaluation of adalimumab effects on left ventricle performance by echocardiography indexes among patients with immunosuppressant refractory ulcerative colitisFrontiers in Medicine 2023; 9 doi: 10.3389/fmed.2022.1008711
7
InfliximabReactions Weekly 2022; 1890(1): 139 doi: 10.1007/s40278-022-09136-y
8
Elżbieta Lazar-Poloczek, Ewa Romuk, Wojciech Jacheć, Wiktoria Stanek, Bartosz Stanek, Monika Szołtysik, Tomasz Techmański, Maja Hasterok, Celina Wojciechowska. Levels of TNF-α and Soluble TNF Receptors in Normal-Weight, Overweight and Obese Patients with Dilated Non-Ischemic Cardiomyopathy: Does Anti-TNF Therapy Still Have Potential to Be Used in Heart Failure Depending on BMI?Biomedicines 2022; 10(11): 2959 doi: 10.3390/biomedicines10112959
9
Lindsey Sellers Coppiano, Dianne May. A Worldwide Yearly Survey of New Data in Adverse Drug ReactionsSide Effects of Drugs Annual 2022; 44: 379 doi: 10.1016/bs.seda.2022.09.012
10
Chendong Peng, Yuang Jiang, Xianhong Ou, Lei Liao, Chengying Yang, Qiao Zhou, Yan Wei, Lijia Chang, Xinrong Fan. Novel XIAP mutation with early-onset Crohn’s disease complicated with acute heart failure: a case reportBMC Cardiovascular Disorders 2023; 23(1) doi: 10.1186/s12872-023-03386-6